Hersh Gupta

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 356 citations · Full text

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition

Joao V. Alessi, Biagio Ricciuti, Liam F. Spurr et al. · Journal of Thoracic Oncology · 2021 · 140 citations

Autoimmune Disease, Immunology, Pathology +9

<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

James M. Cleary, Srivatsan Raghavan, Qibiao Wu et al. · Cancer Discovery · 2021 · 104 citations · Full text

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti, Giuseppe Lamberti, Sreekar Reddy Puchala et al. · Journal of Clinical Oncology · 2024 · 100 citations · Full text

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief et al. · Annals of Oncology · 2022 · 93 citations · Full text

Immunophenotypic Correlates, Oncology, Medicine +8